LTIP1978A - Fucolsylated glycosides as inhibitor of bacterial adherence - Google Patents

Fucolsylated glycosides as inhibitor of bacterial adherence

Info

Publication number
LTIP1978A
LTIP1978A LTIP1978A LTIP1978A LTIP1978A LT IP1978 A LTIP1978 A LT IP1978A LT IP1978 A LTIP1978 A LT IP1978A LT IP1978 A LTIP1978 A LT IP1978A LT IP1978 A LTIP1978 A LT IP1978A
Authority
LT
Lithuania
Prior art keywords
fucolsylated
glycosides
inhibitor
bacterial adherence
adherence
Prior art date
Application number
LTIP1978A
Inventor
Karin Eklind
Hans Lonn
Anna-Karin Tiden
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of LTIP1978A publication Critical patent/LTIP1978A/en
Publication of LT3446B publication Critical patent/LT3446B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
LTIP1978A 1993-06-25 1994-06-27 Fucolsylated glycosides as inhibitor of bacterial adherence LT3446B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK93761A DK76193D0 (en) 1993-06-25 1993-06-25 CARBOHYDRATE DERIVATIVES

Publications (2)

Publication Number Publication Date
LTIP1978A true LTIP1978A (en) 1995-01-31
LT3446B LT3446B (en) 1995-10-25

Family

ID=8097261

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1978A LT3446B (en) 1993-06-25 1994-06-27 Fucolsylated glycosides as inhibitor of bacterial adherence

Country Status (9)

Country Link
EP (1) EP0706528A1 (en)
JP (1) JPH08512026A (en)
AU (1) AU7089194A (en)
CA (1) CA2164961A1 (en)
DK (1) DK76193D0 (en)
IL (1) IL110074A0 (en)
IS (1) IS4181A (en)
LT (1) LT3446B (en)
WO (1) WO1995000527A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6204431B1 (en) 1994-03-09 2001-03-20 Abbott Laboratories Transgenic non-human mammals expressing heterologous glycosyltransferase DNA sequences produce oligosaccharides and glycoproteins in their milk
JPH1160590A (en) * 1997-08-22 1999-03-02 Yakult Honsha Co Ltd Oligofucose derivative or oligorhamnose derivative and its production
SE9901007D0 (en) * 1999-03-19 1999-03-19 Thomas Boren Use of fucosylated sialylated N-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
CN101291946B (en) * 2005-08-09 2011-06-29 糖模拟物有限公司 Glycomimetic inhibitors of the pa-il lectin, pa-iil lectin or both the lectins from pseudomonas
WO2012037034A1 (en) 2010-09-14 2012-03-22 Glycomimetics, Inc. E-selectin antagonists
CA2858099C (en) 2011-12-22 2020-12-15 Glycomimetics, Inc. E-selectin antagonist compounds, compositions, and methods of use
EP2692740A1 (en) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycan compositions, processes for preparing the same and their uses as a drug
DK2928476T3 (en) 2012-12-07 2018-05-22 Glycomimetics Inc RELATIONSHIPS, COMPOSITIONS AND METHODS OF USING E-SELECTIN ANTAGONISTS FOR MOBILIZATION OF HEMATOPOIETIC CELLS
US20150366195A1 (en) * 2013-01-31 2015-12-24 Pioneer Hi-Bred International, Inc. Synthetic lipochitooligosaccharides for improvement of plant growth and yield
US10086054B2 (en) * 2013-06-26 2018-10-02 Academia Sinica RM2 antigens and use thereof
DK3227310T3 (en) 2014-12-03 2019-09-30 Glycomimetics Inc HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINES AND CXCR4-CHEMOKIN RECEPTORS
WO2017127422A1 (en) 2016-01-22 2017-07-27 Glycomimetics, Inc. Glycomimetic inhibitors of pa-il and pa-iil lectins
US11291678B2 (en) 2016-03-02 2022-04-05 Glycomimetics, Inc Methods for the treatment and/or prevention of cardiovascular disease by inhibition of E-selectin
US11433086B2 (en) 2016-08-08 2022-09-06 Glycomimetics, Inc. Combination of T-cell checkpoint inhibitors with inhibitors of e-selectin or CXCR4, or with heterobifunctional inhibitors of both E-selectin and CXCR4
WO2018068010A1 (en) 2016-10-07 2018-04-12 Glycomimetics, Inc. Highly potent multimeric e-selectin antagonists
EP3596096A1 (en) 2017-03-15 2020-01-22 GlycoMimetics, Inc. Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonists
WO2019108750A1 (en) 2017-11-30 2019-06-06 Glycomimetics, Inc. Methods of mobilizing marrow infiltrating lymphocytes and uses thereof
AU2018395417B2 (en) 2017-12-29 2023-07-13 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3
CA3091454A1 (en) 2018-03-05 2019-09-12 Glycomimetics, Inc. Methods for treating acute myeloid leukemia and related conditions
CN112638944A (en) 2018-08-23 2021-04-09 西进公司 anti-TIGIT antibody
KR20210110645A (en) 2018-12-27 2021-09-08 글리코미메틱스, 인크. Galectin-3 Inhibitory C-Glycoside
US11845771B2 (en) 2018-12-27 2023-12-19 Glycomimetics, Inc. Heterobifunctional inhibitors of E-selectin and galectin-3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1603609A (en) * 1977-04-14 1981-11-25 Chembiomed Ltd O-protected 2-azido-2-deoxy-glycosyl nitrates
FR2509313A1 (en) * 1981-07-08 1983-01-14 Choay Sa 3-FUCOSYL-N-ACETYL LACTOSAMINE DERIVATIVES, THEIR PREPARATION AND THEIR BIOLOGICAL APPLICATIONS
DE3220427A1 (en) * 1982-05-29 1983-12-01 Behringwerke Ag, 3550 Marburg SS-D-GALACTOSE DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE
DK17685D0 (en) * 1985-01-14 1985-01-14 Hans Goeran Magnusson glycoside
AU609999B2 (en) * 1988-06-21 1991-05-09 Marion Laboratories, Inc. Bismuth (phosph/sulf)ated saccharides

Also Published As

Publication number Publication date
EP0706528A1 (en) 1996-04-17
WO1995000527A1 (en) 1995-01-05
CA2164961A1 (en) 1995-01-05
IL110074A0 (en) 1994-10-07
AU7089194A (en) 1995-01-17
IS4181A (en) 1994-12-26
DK76193D0 (en) 1993-06-25
JPH08512026A (en) 1996-12-17
LT3446B (en) 1995-10-25

Similar Documents

Publication Publication Date Title
LTIP1978A (en) Fucolsylated glycosides as inhibitor of bacterial adherence
PL313619A1 (en) Derivatives of piperydine
PL310443A1 (en) Derivatives of pyrolo-pyridine
GB9311282D0 (en) New compositions of matter
AU4623193A (en) Corrosion inhibition composition
AU3903993A (en) Water compositions
GB9314412D0 (en) New compositions of matter
GB9302049D0 (en) Compositions of new matter
AU5884094A (en) Sponges of hydrocolloids
AU2390692A (en) Beta-glucuronidase inhibitor
PL306127A1 (en) Derivatives of epi-epibathydine
AU6000794A (en) Cleansing composition
HU9502497D0 (en) Use of oligosaccharide glycosides as inhibitors of bacterial adherence
AU6030896A (en) Methods of inhibiting bacterial sialidase
GB9302072D0 (en) New compositions of matter
GB9311281D0 (en) Novel composition of matter
AU7175094A (en) Inhibition of interferon-gamma with oligonucleotides
AU6723294A (en) Use of simmondsine
AU1850095A (en) Inhibitors of kynureninase
AU3200493A (en) Ganglioside-GM3-fortified nutrient composition
AU7612394A (en) Cleansing composition
AU7565594A (en) Oral compositions of h2-antagonists
ZA939480B (en) Enzyme inhibitor
AU8159594A (en) Novel inhibitor
AU4721093A (en) Detection of microorganisms

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19960627